Exogenous leptin improves cerebral ischemia-reperfusion-induced glutamate excitotoxic injury in mice by up-regulating GLT-1 and GLAST expression in astrocytes

doi:10.12122/j.issn.1673-4254.2024.06.08

Abstract

Abstract:

Objective To investigate the protective effect of exogenous leptin against focal cerebral ischemia-reperfusion (I/R) injury in mice and explore the underlying mechanism. Methods A total of 100 C57BL/6 mice were randomly divided into 5 groups, including a sham-operated group, cerebral I/R model group, and 3 leptin treatment groups with intraperitoneal injections of 0.5, 1.0 or 2.0 leptin immediately after occlusion of the internal carotid artery. At 24 h after reperfusion, neurological function scores of the mice were assessed, and TTC staining was used to determine the area of cerebral infarction. The pathological changes in the cortical brain tissue of the mice were observed using HE staining, and degenerative damage of the cortical neurons were assessed with Fluoro-Jade C staining. The expression of glial fibrillary acidic protein in cortical brain tissues was detected using immunohistochemistry and Western blotting. In another 45 C57BL/6 mice with sham operation, I/R modeling, or leptin (1 mg/kg) treatment, glutamic acid in the cortical brain tissue was detected using glutamate assay, and cortical glutamate-aspartate transporter (GLAST) and glutamate transporter-1 (GLT-1) protein expressions were detected using immunohistochemistry. Results Compared with the I/R model mice, the leptin-treated mice had significantly lower neurological deficit scores, smaller cerebral infarct area, milder pathologies in the cortical brain tissue, and lessened cortical neuronal damage with normal morphology and less excessive proliferation of the astrocytes. Leptin treatment significantly up-regulated the expressions of GLT-1 and GLAST and lowered the content of glutamic acid in the brain tissue of the I/R mice. Conclusion Exogenous leptin has obvious neuroprotective effect against cerebral I/R injury in mice, mediated probably by controlling excessive astrocyte proliferation and up-regulating cortical GLT-1 and GLAST expressions to reduce glutamate-mediated excitotoxic injury of the astrocytes.

Key words: leptin, cerebral ischemia-reperfusion injury, astrocytes, glutamate transporter-1, glutamate-aspartate transporter, excitotoxicity

Jie CHEN, Chenxu LIU, Chun WANG, Li LI, Weiting TAO, Jingru XUN, Honghui TANG, Li HUANG. Exogenous leptin improves cerebral ischemia-reperfusion-induced glutamate excitotoxic injury in mice by up-regulating GLT-1 and GLAST expression in astrocytes[J]. Journal of Southern Medical University, 2024, 44(6): 1079-1087.

Figures/Tables 8

Fig.1 Microscopic observation of mouse right common carotid artery (CCA) and its branches.

Fig.2 Posture of the mice following brain I/R modeling (A) and neurological deficit scores of the mice in different groups (B), n=9. ****P<0.0001 vs Sham group; ####P<0.0001 vs I/R group.

Fig.3 TTC staining for determining the size of cerebral infarct area of the mice. A: TTC staining of the brain tissue sections. B: Quantitative analysis of brain infarct area (n=3). ****P<0.0001 vs Sham group; ###P<0.001, ####P<0.0001 vs I/R group.

Fig.4 HE staining for examining histopathological changes in the cortical brain tissues of the mice (scale bar=20 μm).

Fig.5 FJC staining for assessing cortical neuronal degenerative damage. A: FJC staining iamges (scale bar=20 μm). B: Positive rate of the degenerated neurons. ****P<0.0001 vs Sham group; ####P<0.0001 vs I/R group.

Fig.6 Expression of GFAP protein in mouse cortical brain tissue. A: Expression of GFAP detected by immunohistochemistry (Original magnification: ×40). B: Expression of GFAP detected by Western blotting (n=3). C: Quantitative analysis of GFAP expression. ***P<0.001 vs Sham group; ##P<0.01 vs I/R group.

Fig.7 Expression of GLT-1 and GLAST proteins in mouse cortical brain tissue (×40).

Fig.8 Changes in the expression of GLT-1 and GLAST proteins and Glu content in mouse cortical brain tissue. A: Expression of GLT-1 and GLAST detected by Western blotting (n=3). B: Quantitative analysis of GLT-1 expression. C: Quantitative analysis of GLAST expression; D: Content of Glu (n=3). ***P<0.001, ****P<0.0001 vs Sham group; #P<0.01, ###P<0.001 vs I/R group.

References 33

1	Collaborators G 2 N. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016[J]. Lancet Neurol, 2019, 18(5): 459-80.
2	Campbell BCV, Khatri P. Stroke[J]. Lancet, 2020, 396(10244): 129-42.
3	Ghosh M, Lane M, Krizman E, et al. The transcription factor Pax6 contributes to the induction of GLT-1 expression in astrocytes through an interaction with a distal enhancer element[J]. J Neurochem, 2016, 136(2): 262-75.
4	Kim K, Lee SG, Kegelman TP, et al. Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics[J]. J Cell Physiol, 2011, 226(10): 2484-93.
5	Murphy-Royal C, Dupuis J, Groc L, et al. Astroglial glutamate transporters in the brain: regulating neurotransmitter homeostasis and synaptic transmission[J]. J Neurosci Res, 2017, 95(11): 2140-51.
6	Verkhratsky A, Nedergaard M. Physiology of astroglia[J]. Physiol Rev, 2018, 98(1): 239-389.
7	Danbolt NC, Furness DN, Zhou Y. Neuronal vs glial glutamate uptake: resolving the conundrum[J]. Neurochem Int, 2016, 98: 29-45.
8	Malik AR, Willnow TE. Excitatory amino acid transporters in physiology and disorders of the central nervous system[J]. Int J Mol Sci, 2019, 20(22): 5671.
9	Melone M, Ciriachi C, Pietrobon D, et al. Heterogeneity of astrocytic and neuronal GLT-1 at cortical excitatory synapses, as revealed by its colocalization with Na+/K+-ATPase α isoforms[J]. Cereb Cortex, 2019, 29(8): 3331-50.
10	Roberts RC, Roche JK, McCullumsmith RE. Localization of excitatory amino acid transporters EAAT1 and EAAT2 in human postmortem cortex: a light and electron microscopic study[J]. Neuroscience, 2014, 277: 522-40.
11	Kashem MA, Sultana N, Pow DV, et al. GLAST (GLutamate and ASpartate Transporter) in human prefrontal cortex; interactome in healthy brains and the expression of GLAST in brains of chronic alcoholics[J]. Neurochem Int, 2019, 125: 111-6.
12	Danbolt NC. Glutamate uptake[J]. Prog Neurobiol, 2001, 65(1): 1-105.
13	Suárez-Pozos E, Thomason EJ, Fuss B. Glutamate transporters: expression and function in oligodendrocytes[J]. Neurochem Res, 2020, 45(3): 551-60.
14	Pajarillo E, Rizor A, Lee J, et al. The role of astrocytic glutamate transporters GLT-1 and GLAST in neurological disorders: potential targets for neurotherapeutics[J]. Neuropharmacology, 2019, 161: 107559.
15	Banks WA, Kastin AJ, Huang W, et al. Leptin enters the brain by a saturable system independent of insulin[J]. Peptides, 1996, 17(2): 305-11.
16	Hu SJ, Cheng DB, Peng DT, et al. Leptin attenuates cerebral ischemic injury in rats by modulating the mitochondrial electron transport chain via the mitochondrial STAT3 pathway[J]. Brain Behav, 2019, 9(2): e01200.
17	Zhang WF, Jin YC, Wang D, et al. Neuroprotective effects of leptin on cerebral ischemia through JAK2/STAT3/PGC-1-mediated mitochondrial function modulation[J]. Brain Res Bull, 2020, 156: 118-30.
18	Zhang Y, Cheng DB, Jie CX, et al. Leptin alleviates endoplasmic reticulum stress induced by cerebral ischemia/reperfusion injury via the PI3K/Akt signaling pathway[J]. Biosci Rep, 2022, 42(12): BSR20221443.
19	Longa EZ, Weinstein PR, Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats[J]. Stroke, 1989, 20(1): 84-91.
20	Jiwaji Z, Hardingham GE. Good, bad, and neglectful: Astrocyte changes in neurodegenerative disease[J]. Free Radic Biol Med, 2022, 182: 93-9.
21	Liu ZW, AstrocytesChopp M., therapeutic targets for neuroprotection and neurorestoration in ischemic stroke[J]. Prog Neurobiol, 2016, 144: 103-20.
22	Pekny M, Wilhelmsson U, Pekna M. The dual role of astrocyte activation and reactive gliosis[J]. Neurosci Lett, 2014, 565: 30-8.
23	Michinaga S, Koyama Y. Pathophysiological responses and roles of astrocytes in traumatic brain injury[J]. Int J Mol Sci, 2021, 22(12): 6418.
24	Zhang SF, Shang DS, Shi H, et al. Function of astrocytes in neuroprotection and repair after ischemic stroke[J]. Eur Neurol, 2021, 84(6): 426-34.
25	Mahmoud S, Gharagozloo M, Simard C, et al. Astrocytes maintain glutamate homeostasis in the CNS by controlling the balance between glutamate uptake and release[J]. Cells, 2019, 8(2): 184.
26	Yeh TH, Hwang HM, Chen JJ, et al. Glutamate transporter function of rat hippocampal astrocytes is impaired following the global ischemia[J]. Neurobiol Dis, 2005, 18(3): 476-83.
27	Fontana AC. Current approaches to enhance glutamate transporter function and expression[J]. J Neurochem, 2015, 134(6): 982-1007.
28	Roettger V, Lipton P. Mechanism of glutamate release from rat hippocampal slices during in vitro ischemia[J]. Neuroscience, 1996, 75(3): 677-85.
29	Rossi DJ, Oshima T, Attwell D. Glutamate release in severe brain ischaemia is mainly by reversed uptake[J]. Nature, 2000, 403(6767): 316-21.
30	Shen YL, Lu HL, Xu RN, et al. The expression of GLAST and GLT1 in a transient cerebral ischemia Mongolian gerbil model[J]. Neuropsychiatr Dis Treat, 2020, 16: 789-800.
31	Rao VL, Dogan A, Bowen KK, et al. Antisense knockdown of the glial glutamate transporter GLT-1 exacerbates hippocampal neuronal damage following traumatic injury to rat brain[J]. Eur J Neurosci, 2001, 13(1): 119-28.
32	Naranjo V, Contreras A, Merino B, et al. Specific deletion of the astrocyte leptin receptor induces changes in hippocampus glutamate metabolism, synaptic transmission and plasticity[J]. Neuroscience, 2020, 447: 182-90.
33	Zhang J, Deng Z, Liao J, et al. Leptin attenuates cerebral ischemia injury through the promotion of energy metabolism via the PI3K/Akt pathway[J]. J Cereb Blood Flow Metab, 2013, 33(4): 567-74.

[1]	MAN Hao, WANG Jianwei, WU Mao, SHAO Yang, YANG Junfeng, LI Shaoshuo, LÜ Jinye, ZHOU Yue. Jisuikang formula promotes spinal cord injury repair in rats by activating the YAP/PKM2 signaling axis in astrocytes [J]. Journal of Southern Medical University, 2024, 44(4): 636-643.
[2]	SUN Wei, CHEN Ping, TANG Xiaohang, GU Yingmin, TIAN Xuesong. An improved 4-vessel intermittent occlusion method for establishing rat models of global cerebral ischemia-reperfusion injury [J]. Journal of Southern Medical University, 2023, 43(7): 1194-1203.
[3]	ZHAO Huanling, LING Yuxiao, MI Shuai, ZHU Jiahao, FAN Jiayao, YANG Ye, WANG Jing, LI Yingjun. Associations of circulating leptin levels with colorectal adenoma and colorectal cancer: a case-control and Mendelian randomization study [J]. Journal of Southern Medical University, 2023, 43(12): 1989-1997.
[4]	CAO Tianran, LIU Qingfang, PAN Meimin, ZHANG Xuehong. LncRNA SNHG8 inhibits miR-494-3p expression to alleviate cerebral ischemia-reperfusion injury in mice [J]. Journal of Southern Medical University, 2023, 43(12): 2015-2022.
[5]	XING Yao, LIU Ziyao, ZHANG Xiaohui, WANG Jianming. Effects of leptin on proliferation and differentiation of hypoxic rat retinal progenitor cells in vitro [J]. Journal of Southern Medical University, 2022, 42(3): 354-359.
[6]	. Exogenous hydrogen sulfide inhibits high-glucose-induced injuries via regulating leptin/ leptin receptor signaling pathway in human umbilical vein endothelial cells [J]. Journal of Southern Medical University, 2016, 36(08): 1055-.
[7]	. Src kinase inhibitor PP2 protects rat astrocytes from hypoxia/reoxygenation injury in vitro [J]. Journal of Southern Medical University, 2015, 35(02): 239-.
[8]	. Impact of topographic features of electrospun polymethylmethacrylate nanofibers on growth pattern of rat primary astrocytes [J]. Journal of Southern Medical University, 2014, 34(11): 1569-.
[9]	. Association of leptin receptor gene polymorphisms with hypertension in Chinese population: a meta-analysis [J]. Journal of Southern Medical University, 2014, 34(02): 265-.
[10]	. Effects of immunization with recombinant fusion protein of extracellular neartransmembrane domain of Tibet minipig leptin receptor on fat deposition in SD rats [J]. Journal of Southern Medical University, 2013, 33(06): 832-.
[11]	. [J]. Journal of Southern Medical University, 2013, 33(04): 463-.
[12]	. Expression of connexin43and functional modulation of gap junction in neonatal rat astrocytesin vitro [J]. Journal of Southern Medical University, 2012, 32(10): 1423-.
[13]	HU Zhong-wei, GUO Jia-wei, DENG Xi-long Department of Gastroenterology, Eighth People’s Hospital, Guangzhou 510060, China. Association of serum leptin and insulin resistance with nonalcoholic fatty liver disease [J]. Journal of Southern Medical University, 2006, 26(06): 853-855.
[14]	LIN Ji1, YAN Guang-tao1, GAO Xiao-ning2, LIAO Jie3, HAO Xiu-hua1, ZHANG Kai1 1Research Laboratory of Biochemistry, 2Department of Pediatrics, 3Medical and Laboratory Analysis Center, General Hospital of PLA, Beijing 100853, China. Effect of intestinal ischemia/reperfusion injury on leptin and orexin-A levels [J]. Journal of Southern Medical University, 2006, 26(06): 719-724.
[15]	MA Ren-qiang¹, CHEN Jian-wen¹, PANG Jian-xin², LAN Xiu-jian³, QIU Can-hua³. Protective effects of total paeony glycoside against global cerebral ischemia-reperfusion injury in gerbils [J]. Journal of Southern Medical University, 2005, 25(04): 471-473.